Literature DB >> 35644252

TGFβ signaling is required for sclerotome resegmentation during development of the spinal column in Gallus gallus.

Sade W Clayton1, Allyson Angermeier2, Jacob E Halbrooks2, Ronisha McCardell3, Rosa Serra4.   

Abstract

We previously showed the importance of TGFβ signaling in development of the mouse axial skeleton. Here, we provide the first direct evidence that TGFβ signaling is required for resegmentation of the sclerotome using chick embryos. Lipophilic fluorescent tracers, DiO and DiD, were microinjected into adjacent somites of embryos treated with or without TGFβRI inhibitors, SB431542, SB525334 or SD208, at developmental day E2.5 (HH16). Lineage tracing of labeled cells was observed over the course of 4 days until the completion of resegmentation at E6.5 (HH32). Vertebrae were malformed and intervertebral discs were small and misshapen in inhibitor injected embryos. Hypaxial myofibers were also increased in thickness after treatment with the inhibitor. Inhibition of TGFβ signaling resulted in alterations in resegmentation that ranged between full, partial, and slanted shifts in distribution of DiO or DiD labeled cells within vertebrae. Patterning of rostro-caudal markers within sclerotome was disrupted at E3.5 after treatment with TGFβRI inhibitor with rostral domains expressing both rostral and caudal markers. We propose that TGFβ signaling regulates rostro-caudal polarity and subsequent resegmentation in sclerotome during spinal column development.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axial skeleton; Resegmentation; Somites; TGFβ

Mesh:

Substances:

Year:  2022        PMID: 35644252      PMCID: PMC9552462          DOI: 10.1016/j.ydbio.2022.05.013

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.148


  47 in total

1.  An ex-ovo chicken embryo culture system suitable for imaging and microsurgery applications.

Authors:  Huseyin C Yalcin; Akshay Shekhar; Ajinkya A Rane; Jonathan T Butcher
Journal:  J Vis Exp       Date:  2010-10-23       Impact factor: 1.355

2.  A role for WNT proteins in induction of dermomyotome.

Authors:  C M Fan; C S Lee; M Tessier-Lavigne
Journal:  Dev Biol       Date:  1997-11-01       Impact factor: 3.582

3.  Avian intervertebral disc arises from rostral sclerotome and lacks a nucleus pulposus: implications for evolution of the vertebrate disc.

Authors:  Bradley J Bruggeman; Jennifer A Maier; Yasmin S Mohiuddin; Rae Powers; Yinting Lo; Nuno Guimarães-Camboa; Sylvia M Evans; Brian D Harfe
Journal:  Dev Dyn       Date:  2012-02-21       Impact factor: 3.780

4.  Activator-to-repressor conversion of T-box transcription factors by the Ripply family of Groucho/TLE-associated mediators.

Authors:  Akinori Kawamura; Sumito Koshida; Shinji Takada
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

Review 5.  Non-Smad pathways in TGF-beta signaling.

Authors:  Ying E Zhang
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 6.  Dil and diO: versatile fluorescent dyes for neuronal labelling and pathway tracing.

Authors:  M G Honig; R I Hume
Journal:  Trends Neurosci       Date:  1989-09       Impact factor: 13.837

7.  The contribution made by a single somite to the vertebral column: experimental evidence in support of resegmentation using the chick-quail chimaera model.

Authors:  K M Bagnall; S J Higgins; E J Sanders
Journal:  Development       Date:  1988-05       Impact factor: 6.868

8.  Determination of epithelial half-somites in skeletal morphogenesis.

Authors:  R S Goldstein; C Kalcheim
Journal:  Development       Date:  1992-10       Impact factor: 6.868

9.  IVD Development: Nucleus pulposus development and sclerotome specification.

Authors:  Bashar Alkhatib; Ga I Ban; Sade Williams; Rosa Serra
Journal:  Curr Mol Biol Rep       Date:  2018-07-13

10.  Resegmentation is an ancestral feature of the gnathostome vertebral skeleton.

Authors:  Katharine E Criswell; J Andrew Gillis
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.